Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting

Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence
Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence
Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence
Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence
Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence
Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence
Hematology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence
Haematologica Early view Sep 5, 2024 https://doi.org/10.3324/haematol.2024.285934

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2024.285934
 
Published
2024-09-05
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2024 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
278
PDF Downloads
118

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online